Tilray Inc (NASDAQ:TLRY – Get Free Report) shares fell 0.3% during mid-day trading on Friday . The stock traded as low as $1.69 and last traded at $1.70. 6,873,704 shares traded hands during trading, a decline of 73% from the average session volume of 25,149,152 shares. The stock had previously closed at $1.70.
Tilray Trading Down 0.6 %
The company has a debt-to-equity ratio of 0.10, a current ratio of 2.27 and a quick ratio of 1.42. The stock has a market cap of $1.31 billion, a price-to-earnings ratio of -3.84 and a beta of 2.13. The company’s fifty day moving average price is $1.78 and its 200-day moving average price is $1.87.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The company had revenue of $229.90 million for the quarter, compared to analyst estimates of $226.20 million. During the same quarter last year, the company earned ($0.15) EPS. The business’s revenue was up 24.8% compared to the same quarter last year. On average, research analysts expect that Tilray Inc will post -0.16 EPS for the current fiscal year.
Hedge Funds Weigh In On Tilray
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
- Five stocks we like better than Tilray
- What Are Dividend Achievers? An Introduction
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- Consumer Discretionary Stocks Explained
- MarketBeat Week in Review – 9/30 – 10/4
- How to buy stock: A step-by-step guide for beginners
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.